This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,143,676
Targeting soluble epoxide hydrolase to treat age-related macular degeneration
CIHR · 2026 · Nominated PI
Targeting soluble epoxide hydrolase to treat age-related macular degeneration
Principal investigators: Corson, Timothy W
Keywords: Age-Related Macular Degeneration; Angiogenesis; Drug Discovery; Inflammation; Lipids; Mouse Model; Pharmacology; Retinal Pigment Epithelium; Soluble Epoxide Hydrolase; Target Validation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.